| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0169-5002(00)00239-7 |
| P698 | PubMed publication ID | 11390004 |
| P50 | author | Deborah Marshall | Q38544106 |
| P2093 | author name string | Chu C | |
| Simpson KN | |||
| Earle CC | |||
| P2860 | cites work | The effect of surgical treatment on survival from early lung cancer. Implications for screening | Q52423573 |
| Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening. | Q52924849 | ||
| Results of surgery for primary lung cancer based on the new international staging system. | Q53343111 | ||
| Screening for lung cancer | Q73898920 | ||
| Cost-effectiveness decision analysis of mass screening for lung cancer | Q77340555 | ||
| Are increasing 5-year survival rates evidence of success against cancer? | Q28139089 | ||
| Surgical therapy of early non-small cell lung cancer | Q28142655 | ||
| Revisions in the International System for Staging Lung Cancer | Q28241070 | ||
| Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993 | Q28281809 | ||
| Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography | Q28297919 | ||
| Measuring effectiveness of lung cancer screening: from consensus to controversy and back | Q38555726 | ||
| Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care | Q39386468 | ||
| Screening for lung cancer. Another look; a different view | Q41445352 | ||
| The influence of lung cancer mass screening on surgical results | Q43760940 | ||
| Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis | Q44747375 | ||
| Length and lead time biases in radiologic screening for lung cancer | Q44954782 | ||
| The importance of sputum cytology in the diagnosis of lung cancer: a cost-effectiveness analysis | Q46131494 | ||
| Early Lung Cancer Action Project: overall design and findings from baseline screening. | Q50649665 | ||
| Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. | Q52075219 | ||
| P433 | issue | 3 | |
| P921 | main subject | lung cancer | Q47912 |
| cost-effectiveness analysis | Q1754768 | ||
| P304 | page(s) | 227-236 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Lung Cancer | Q641464 |
| P1476 | title | Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. | |
| P478 | volume | 32 |
| Q37079386 | A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions |
| Q35854588 | Building better models: if we build them, will policy makers use them? Toward integrating modeling into health care decisions |
| Q35019490 | CT screening: a trade-off of risks, benefits, and costs |
| Q28749665 | Calibration methods used in cancer simulation models and suggested reporting guidelines |
| Q99608025 | Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model |
| Q36961094 | Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis |
| Q36973577 | Computed tomography screening for lung cancer: review of screening principles and update on current status |
| Q37345335 | Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening. |
| Q30251912 | Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review |
| Q35104187 | Cost-effectiveness of CT screening in the National Lung Screening Trial |
| Q36537744 | Could CT screening for lung cancer ever be cost effective in the United Kingdom? |
| Q35991264 | Decision making in patients with pulmonary nodules |
| Q51125454 | Detection of small pulmonary nodules in high-field MR at 3 T: evaluation of different pulse sequences using porcine lung explants. |
| Q35801394 | ESR/ERS white paper on lung cancer screening |
| Q41952990 | ESR/ERS white paper on lung cancer screening. |
| Q50682780 | Economic decision analysis model of screening for lung cancer. |
| Q91619586 | Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer |
| Q33620462 | Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study |
| Q33204061 | Global registries for measuring pharmacoeconomic and quality-of-life outcomes: focus on design and data collection, analysis and interpretation |
| Q53310756 | IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001. |
| Q26784107 | Implementing lung cancer screening in the real world: opportunity, challenges and solutions |
| Q34569420 | Lung cancer evolution to preinvasive management |
| Q83394751 | Lung cancer screening |
| Q38155065 | Lung cancer screening: review and performance comparison under different risk scenarios |
| Q35627761 | Lung cancer screening: will the controversy extend to its cost-effectiveness? |
| Q35009949 | Lung cancer. 2: screening and early diagnosis of lung cancer |
| Q37128760 | Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs |
| Q51060388 | Moving to the routine management of pre symptomatic lung cancer. |
| Q35037686 | Screening for lung cancer: in pursuit of pre-metastatic disease |
| Q58770863 | The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer |
| Q41521258 | Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting |
Search more.